| Name | Title | Contact Details |
|---|
Neurowave Medical Technologies is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Cloudbreak is a language access and telehealth company that has been around for over 16 years. In the course of building out the technology powering our Martti video remote interpretation solution, we developed unparalleled understanding of networks, video traffic, and the technology to enable them.
Capital Home Health Care is a Leesburg, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Eyecarrot’s goal is to power a global, data-driven, expert therapeutic network to transform how human Oculomotor Sensory performance is diagnosed, exercised and enhanced. The company is building Binovi, a universal, collaborative care platform that integrates software, hardware, data and the expert knowledge and insights of vision care professionals to help patients on a global scale.